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Mutations in the unconventional myosin VI gene, Myo6, are associated with deafness and vestibular dysfunction
in the Snell’s waltzer (sv) mouse. The corresponding human gene, MYO6, is located on chromosome 6q13. We
describe the mapping of a new deafness locus, DFNA22, on chromosome 6q13 in a family affected by a nonsyn-
dromic dominant form of deafness (NSAD), and the subsequent identification of a missense mutation in theMYO6
gene in all members of the family with hearing loss.
Unconventional myosins were among the first family of
proteins found to be associated with hearing loss. Mu-
tations in shaker-1 mutant mice and human Usher syn-
drome type 1B were identified in the myosin VIIA gene
(MIM 276903) simultaneously; not long afterwards,
forms of both dominant and recessive human hearing
loss were found to be associated with myosin VIIA mu-
tations (Gibson et al. 1995; Weil et al. 1995; Liu et al.
1997a, 1997b). Mutations in the unconventionalmyosin
VI gene (Myo6 [MIM 600970]), were found to be as-
sociated with deafness and vestibular dysfunction in the
Snell’s waltzer (sv) mouse (Avraham et al. 1995). A third
unconventional myosin, myosin XV (MIM 602666), is
associated with the DFNB3 locus on chromosome 17
and in the shaker-2 mutant mouse (Probst et al. 1998;
Wang et al. 1998). Despite the concordance between
human and mouse mutations of myosin VIIA and my-
osin XV (among the many loci mapped over the years
for human nonsyndromic hearing loss), none mapped to
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the homologous human region of the sv locus. This re-
port demonstrates the first identification of a mutation
in myosin VI associated with human hearing loss.
We included a large Italian kindred affected by NSAD
(fig. 1A) in a genomewide search. The family is affected
by progressive postlingual sensorineural deafness, with
onset during childhood (8–10 years old at the onset of
symptoms; 6–8 years old at the first audiometric ab-
normalities). At the age of ∼50 years, affected individ-
uals invariably have profound sensorineural deafness.
Audiograms showed different degrees of hearing im-
pairment, with sensorineural hearing loss that ranged in
severity from moderate to profound (fig. 1B). Results of
tympanometric testing indicated proper functioning of
the tympanic membrane and middle ear (data not
shown). Vestibular and/or visual involvement was ex-
cluded in all affected individuals. The genomewide
search was performed using the ABI PRISM linkage
mapping set (Perkin Elmer), characterized by 1375
markers that define a human index map with a 10-cM
resolution. PCR amplifications, using fluorescence-
labeled primers were performed under the conditions
recommended by the supplier. An aliquot of each PCR
product was tested on an ABI Prism 377DNA sequencer,
and results were processed by GENESCAN software.
Allele assignation was performed using GENOTYPER
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Figure 1 An MYO6 mutation in affected members of an Italian kindred. Top, Pedigree of four generations of the Italian family, showing
haplotypes of chromosome 6q13markers (D6S257, D6S402, D6S681, D6S640, andDS445) and linkage to this region (yellow) in deaf individuals.
Individuals with hearing loss are indicated by blackened symbols; unaffected individuals are indicated by open symbols. Bottom, Pure-tone
audiograms, for right and left ears, of five affected family members. Note variability in severity of hearing loss (moderate to profound) among
siblings.
software. Statistical analysis was performed on the basis
of an autosomal disease with complete penetrance, be-
cause all individuals were older than the mean age at
onset and because their disease status was well defined
by clinical observation and testing. The disease-gene fre-
quency was set to .012, and all marker alleles were con-
sidered to be equally frequent. Pairwise linkage analysis
was performed using the MLINK program, version 5.1,
from the LINKAGE computer software package (Ott
1992). Values for maximum LOD score were calculated
with the ILINK program from the same software pack-
age. The ∼95% confidence limits for the maximum re-
combination fraction (vmax) at the maximum LOD score
(Zmax) were calculated by the 1-LOD-down method (Ott
1992). Alleles were down-coded without loss of inform-
ativeness, to reduce computing time. Pairwise linkage
analysis showed with marker D6S460. WeZ p 5.11max
further investigated this region with additional markers
(D6S257, D6S402, D6S1681, and D6S445), confirming
linkage (table 1) and narrowing the candidate region to
∼11 cM between markers D6S257 and D6S445. The
locus symbol DFNA22 has been assigned to this new
NSAD locus.
KCNQ5, a member of the KCNQ potassium-channel
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Table 1
Pairwise LOD Scores between Deafness and Chromosome 6
Markers
MARKER
LOD SCORE AT v p
Zmax vmax.0 .01 .05 .10 .20 .30 .40
D6S257  2.74 3.15 3.08 2.56 1.81 .89 3.16 .05
D6S402 5.41 5.33 4.99 4.54 3.57 2.47 1.22 5.41 .00
D6S1681 3.31 3.25 3.04 2.76 2.14 1.45 .67 3.31 .00
D6S460 5.11 5.03 4.71 4.29 3.37 2.33 1.14 5.11 .00
D6S445  1.34 2.34 2.64 2.37 1.74 .87 2.64 .10
Figure 2 Top, Affected members were heterozygous for a GrA
transition in exon 12 at position 1325 of the MYO6 cDNA. Bottom,
Restriction enzyme analysis with HpaI mutagenesis primers (IdirA
forward primer 5′-TTAGGTGCACTCTGTGGCAT-3′ and 9* (corre-
sponding to fragment 9 of the gene) reverse mutagenesis primer 5′-
GGATGATGTTTCAAAAGGTTAA-3′) identifies the GrA mutation
in DFNA22 affected individuals. M p mutant; N p normal; NDp
not digested.
family, which combines with KCNQ3 (MIM 602232)
to form functional heteromeric channel proteins, maps
to this region. We examined its expression in the cochlea
to determine whether it was a potential candidate for
deafness. This gene was considered a candidate because
of the association of another member of the potassium
channel genes, KCNQ4, to dominant deafness (Coucke
et al. 1999; Kubisch et al. 1999). Primers were designed
flanking 444 bp of mouse KCNQ5 mRNA sequence,
and PCR was performed on cDNA derived from mouse
cochlea. A product was obtained, indicating positive ex-
pression in the cochlea (data not shown). Primers span-
ning the exon-intron junctions were also designed, and
DNA from the Italian family was screened. No muta-
tions were found to segregate with hearing loss in this
family (data not shown).
The human MYO6 gene also maps within this region
and was considered an excellent candidate on the basis
of its chromosomal location, cochlear expression, and
function. The entire MYO6 coding sequence and all
exon-intron boundaries were scanned for mutations by
sequencing and by analysis of single-strand conforma-
tion polymorphism (Ahituv et al. 2000) (data not
shown). We detected a GrA transition in exon 12 at
position 1325 of the cDNA sequence (relative to the
ATG, designated 1), which replaces a cysteine (TGT)
with a tyrosine (TAT) at residue 442 of the protein
(C442Y) (fig. 2A). This substitution can be analyzed by
a mutagenesis primer that creates an HpaI restriction
site (fig. 2B). All affected members of this family carried
the C442Y mutation, although it was never found in
400 normal chromosomes. The analysis of the coding
region and exon-intron boundaries ofMYO6 gene in 50
Spanish and Italian families with NSAD identified sev-
eral nucleotide variants (not shown) that do not lead to
amino acid changes or did not segregate with deafness.
The C442Y mutation affects a cysteine residue in the
motor domain that is conserved across other myosin VI
species, including human, mouse, chicken, pig, striped
bass, and sea urchin (fig. 3A). In the Caenorhabditis
elegans and Drosophila melanogaster myosin VI, a sim-
ilar hydrophilic amino acid, serine, resides at this po-
sition. Comparison of this residue in a pairwise align-
ment of 143 myosins revealed no changes to tyrosine.
Further analysis of this site, using ConSurf (an algorith-
mic tool recently developed for the identification of func-
tional regions in proteins by surface-mapping of phylo-
genetic information) (Armon et al. 2001), reveals that
C442Y is located in a position that is conserved at a
rate greater than the average among 50 other myosins.
Because the primary structures of myosin motor do-
mains are conserved, we were able to use homology-
modeling techniques to create a three-dimensionalmodel
of myosin VI, using the known structure of myosin II
(Rayment et al. 1993) (fig. 3B). According to the model
shown, the cysteine is partly buried in the protein core,
and, if this is the case, replacement of a small amino
acid by a bulky one, such as tyrosine, is very likely to
destabilize the protein, leading to partial or complete
loss of function.
Myosin VI is a member of the superfamily of myosins
that hydrolyzes ATP, converting chemical energy to me-
chanical force in order to move unidirectionally along
actin filaments. Myosin VI has the unique feature of
being the only motor molecule that is known to move
toward the pointed (negative) end of actin filaments
(Wells et al. 1999). In the inner ear, myosin VI expression
is localized within the inner and outer hair cells of the
sensory epithelium and, within these cells, is concen-
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Figure 3 The C442Y missense mutation. Top, Alignment of a portion of myosin VI from various species. Bottom, A ribbon representation
of a three-dimensional model of the myosin VI motor domain. Inset, the model of myosin VI (blue) and the experimentally determined structure
of chicken pectoralis myosin II (gold), which was used as template. Also shown are C442 (yellow), a-helixes (red), and b-sheets (turquoise).
The model was built using the automatic homology modeling facility, Swiss Model, and the three-dimensional structures of several myosins,
including the Dictyostelium discoideum myosin S1 and chicken pectoralis myosin II motor domain. The figure was created using INSIGHT and
WebLabViewerLite, version 3.10 (MSI).
trated at the base of the stereocilia that contain the neg-
ative ends of actin filaments (Avraham et al. 1997; Has-
son et al. 1997). Myosin VI plays a key role in cell
motility and shape-change events (reviewed by Cramer
2000), including the invagination of the plasma mem-
brane that is observed during pseudocleavage in D.
melanogaster embryo blastoderms (Mermall and Miller
1995), during sperm individualization in D. melano-
gaster (Hicks et al. 1999) and C. elegans (Kelleher et al.
2000), and during stereocilial development in mice (Self
et al. 1999). One Snell’s waltzer allele (sv) contains an
intragenic deletion of the Myo6 gene (Avraham et al.
1995). In this mutant, most stereocilial bundles have a
normal appearance at birth, although signs of disorgan-
ization of the bundles are already present. At 1 d after
birth, early signs of fusion, beginning at the base of the
stereocilia, are observed. This fusion progresses along
the length of the stereocilia so that, by the age of 20 d,
giant stereocilia are seen, along with degeneration of hair
cells. The fusion appears to be specific to the lack of
myosin VI, because no stereocilial fusion is observed in
other deaf mouse mutants, including those with muta-
tions in unconventional myosins (Gibson et al. 1995;
Probst et al. 1998). Myosin VI expression is reduced (to
11%–16% of levels found in the inner ear of wild-type
mice) in a second Snell’s waltzer allele, sesv, leading to
deafness (Avraham et al. 1995).
The C442Y missense mutation in the motor domain
may compromise myosin VI function in a dominant-
negative manner and/or cause haploinsufficiency. We
speculate that the C422Y mutation might reduce avail-
ability of myosin VI in the terminally differentiated hair
cells, leading to stereocilial fusion in the human inner
ear and subsequently impairing proper auditory function
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in a progressive manner. Construction of the appropriate
mouse model will help to address this hypothesis.
Our results provide the first evidence of a role for
myosin VI in human hearing loss, and we have several
reasons for proposing C442Y as the causative mutation.
First, myosin VI is a strong candidate gene, located
within the region defined by DFNA22, found to be mu-
tated. Second, other unconventional myosin mutations
(VIIA and XV) are associated with different forms of
both mouse and human hearing loss. Third, thismissense
mutation cosegregates with hearing loss in the Italian
family and is not present in normal chromosomes.
Fourth, a cysteine or amino acid with a similar hydro-
philic nature is present in all myosin VI proteins at this
position. Despite the effort that has been made to iden-
tify an MYO6 gene mutation in the hearing-impaired
population (Ahituv et al. 2000), this is the first report
that relates MYO6 and the corresponding mouse model
to a form of human deafness, emphasizing the successful
use of mouse models in predicting human disease.
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